Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_assertion type Assertion NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_head.
- NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_assertion description "[KRAS (P=0.0075) or GNAS mutations (P=0.0256) were associated with poor overall survival in all patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_provenance.
- NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_assertion evidence source_evidence_literature NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_provenance.
- NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_assertion SIO_000772 24186137 NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_provenance.
- NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_assertion wasDerivedFrom befree-2016 NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_provenance.
- NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_assertion wasGeneratedBy ECO_0000203 NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_provenance.